Pfizer Finesses Their Brand Identity

Pfizer, “the world’s largest research-based pharmaceutical company”, recently released a refreshed brand identity.  For most people the logo update will go unnoticed, but the overall brand identity (colors, fonts and design style) have been upgraded dramatically.  According to Siegel+Gale, the agency behind the design strategy, the new logo “signals positive change and forward momentum and asks people to take a fresh look at Pfizer because it is not the same company it was in 1991″ (the last time the logo was refreshed).
pfizer_new_logo

The most noticeable difference in the new logo is the oval shape, which was tilted to create a more dynamic arrangement.  Subtle changes to every character in the font have resulted in a more rounded, friendlier and soothing feel, with the biggest changes coming to the “z” and the “e”.

pfizer_color_palette

The new color palette is bold and fluorescent and contains a lot of visual energy.

pfizer_new_home_page

Pfizer’s new identity also carries a strong circular theme, as evidenced in their new home page pictured above.  Overall, this is the right move for a global brand that has produced two of the most popular drugs in the world: Lipitor and Viagra.  The change positions them as a more progressive and lively brand that is helping to change lives for the better.  I applaud them on this strategic step and believe it’s a boost to their brand resonance.

Share this post:
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • LinkedIn
  • Reddit
  • StumbleUpon
  • Technorati
  • Twitter
  • Yahoo! Buzz
  • Posterous
  • Propeller

Tags: , ,

This entry was posted on Wednesday, November 4th, 2009 at 12:47 pm and is filed under Branding & Design. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.


One Response to “Pfizer Finesses Their Brand Identity”

  1. glasnost Says:

    March 19th, 2010 at 4:09 pm

    Well Done! I Like it!

Leave a comment:





(comments are subject to approval)